the quarterly was released 19/4 last year, so we could get it...

the quarterly was released 19/4 last year, so we could get it this week or the following.

ADO's technicals look very average, ( apart from E's monthly chart ) but nothing has changed with the fundamentals in the past week other than the company will now have +$6M in the bank.

the quarterly will give the company the opportunity to outline how the fundamentals have progressed and what they plan to do with the money in more detail

- how production plant commissioning is going and how quickly plans for the expansion to 80K litres are planned. ( 80k litres at $400 per litre, enough anteoX for 80000 ev's only)

- give a more detailed plan of this "grant program will cover the purchase and installation of anode prototyping and pouch cell assembly equipment to enable the delivery of cells in commercial formats for customer evaluation and testing."

- we have been told we have 10 priority CET partners. we know a little about ev1 and we had this

"Furthermore, AnteoTech is in partnership with leading consumer companies that deal with wearable technology, such as electric watches and earbuds. A materials transfer agreement was recently signed with a notable company in Europe to assess the use of AnteoX in these products."

give the shareholders the advances with these 2 and how much the other 8 have progressed (if any)

- the progression in testing of Anteotech's own proprietary ultra high silicon anode containing 70% silicon

- was the order from Serum institute a one off or a continuing partnership

- the release timing of Anteobind NXT

- how are the other non dilutionary funding applications are progressing

probably more than just the above, but the next couple of weeks gives management a great opportunity to show the market the vision of the future and developments that are actually happening at the moment.